Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
Doctoral education pilot in precision cancer medicine launches in 2024
The doctoral education pilot in precision cancer medicine was granted with 152 doctoral positions and 38,8 million EUR funding. It…
Potilas-tutkijatapaaminen Tampereella 6.3.24 – teemana suolistosyöpien tutkimus
Maaliskuu on suolistosyövän tietoisuuskuukausi. Sen kunniaksi iCAN järjestää yhteistyössä Suolistosyöpäyhdistys Coloreksen kanssa suolistosyöpään sairastuneille, heidän läheisilleen ja kaikille aiheesta kiinnostuneille…
iCAN science seminar on March 6 with Dr. Arafath (Rafa) Najumudeen
You are warmly welcome to iCAN science seminar on Wed 6.3.2024 at 13:30-14:30,Biomedicum, seminar room 1-2 or online. Speaker: Dr. Arafath (Rafa)…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding